.png?width=2400&height=263&name=Emergent-BioServices_CMYK_Logo-Tagline-Lockup%20(2).png "Emergent BioSolutions CDMO"){kind=logo}
11.30.2023
3 Things Manufacturers Need to Know About the New Annex 1 Revision
In August 2023, long-awaited drug manufacturing regulations took effect with the implementation of the European Commission’s...
07.20.2023
Outsourced Pharma Capacity Update | July 2023
Kevin Yarnall, Sr. Manager, Manufacturing, presented Emergent's manufacturing capabilities and available capacity at its...
03.22.2023
How to Mitigate Risk for Biologics During Fill/Finish Manufacturing
As more biologics move through research and development, the demand for specialized aseptic fill/finish services has steadily...
11.30.2022
An Inside Look at Drug Product Manufacturing
Emergent's drug product manufacturing facility in Rockville, MD is home to the groninger® INTEGRA, a state-of-the-art high speed...
11.04.2022
Outsourced Pharma Capacity Update
Did you miss the large molecule Outsourced Pharma Capacity Update last month? Download the ondemand presentation to learn more...
10.04.2022
Focus on Fill and Finish
Kelly Christiansen, vice president & general manager of Emergent CDMO's Rockville drug product manufacturing facility recently...